Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists

(7:43)

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

(6:11)

How does Dapagliflozin work? Understanding SGLT2 inhibitors.

(6:57)

Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'

(26:43)

How SGLT2 Inhibitors Protect The Kidney

(16:24)

Type 2 Diabetes: The Benefits and Cost-Effectiveness of SGLT2 Inhibitors

(41:4)

Why SGLT2 Inhibitors Cause Euglycemic DKA

(11:1econd)

Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors

(2:51)

SGLT2 Inhibitors and Heart Failure

(8:15)

What are SGLT2 inhibitors and how do they affect kidney disease?

(10:55)

What are SGLT2 inhibitors - Chronic Kidney Disease | UHL NHS Trust

(3:23)

SGLT-2 Inhibitors, Explained: How They Work, Their Benefits and Risks

(3:35)

When Should We Use SGLT2 Inhibitors?

(12:28)

Step into a world of enhanced diabetes management with GLP-1 and SGLT2 inhibitors!

(53)

SGLT2 Inhibitors in Chronic Kidney Disease

(9:6)

Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting

(50:30)

SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In

(15:34)

Choosing Among Antidiabetes Agents

(5:29)

Evolution of SGLT2 Inhibitors from management of glycemic control , Dr. Sanjay Kaul, MD

(1:3:41)

SGLT2 Inhibitors are Associated With Reduced CV Disease in Type 2 Diabetes

(5:7)